The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model

Peptides

Volumn 28, Issue 12, 2007, Pages 2293-2298

  Minardi, Daniele ^a   Ghiselli, Roberto ^a   Cirioni, Oscar ^a   Giacometti, Andrea ^a   Kamysz, Wojciech ^b   Orlando, Fiorenza ^c   Silvestri, Carmela ^a   Parri, Gianni ^a   Kamysz, Elzbieta ^d   Scalise, Giorgio ^a   Saba, Vittorio ^a   Giovanni, Muzzonigro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c INRCA   (Italy)

^d UNIVERSITY OF GDA SK   (Poland)

Author keywords

Bacterial adhesion; Biofilm; Peptides; Tachyplesin III; Ureteral stents; Urinary tract infections

Indexed keywords

PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; TACHYPLESIN 111; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BIOFILM; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; GRAM NEGATIVE INFECTION; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; URETER STENT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL ADHESION; BIOFILMS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DRUG-ELUTING STENTS; MALE; PENICILLANIC ACID; PEPTIDES, CYCLIC; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS; RATS, WISTAR; URETERAL DISEASES;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RATTUS;

EID: 36148944468     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.10.001     Document Type: Article

References (31)

1. Balaban N., Goy Y., Bitler A., and Boelaert J.R. Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells. Kidney Int 63 (2003) 340-345
2. Beiko D.T., Knudsen B.E., Watterson J.D., Cadieux P.A., and Densted J.D. Urinary tract biomaterials. J Urol 171 (2004) 2438-2444
3. Cirioni O., Giacometti A., Ghiselli R., Dell'Acqua G., Orlando F., Mocchegiani F., et al. RNAIII inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J Infect Dis 193 (2006) 180-186
4. Cirioni O., Giacometti A., Ghiselli R., Bergnach C., Orlando F., Mocchegiani F., et al. Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides 27 (2006) 2104-2110
5. Cirioni O., Giacometti A., Ghiselli R., Kamysz W., Orlando F., Mocchegiani F., et al. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides 27 (2006) 1210-1216
6. Cirioni O., Giacometti A., Kamysz W., Silvestri C., Riva A., Della Vittoria A., et al. In vitro activities of the antimicrobial peptide Tachyplesin III against Pseudomonas aeruginosa. Peptides 28 (2007) 747-751
7. Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6 (2003), CLSI, Villanova, PA
8. Costerton W., Veeh R., Shirtliff M., Pasmore M., Post C., and Ehrich G. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112 (2003) 1466-1477
9. Denstedt J.D., Wollin T.A., and Reid G. Biomaterials used in urology: current issues of biocompatibility, infection and encrustation. J Endourol 12 (1998) 493-500
10. Donlan R.M., and Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2002) 167-170
11. Giacometti A., Cirioni O., Kamysz W., Silvestri C., Licci A., Riva A., et al. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. Peptides 26 (2005) 2111-2116
12. Farsi H.M.A., Mosli H.A., and Al-Zemaity A. Bacteriuria and colonization of doublepigtail ureteral stents: long-term experience with 237 patients. J Endourol 9 (1995) 469-473
13. Goto T., Nakame Y., Nishida M., and Ohi Y. In vitro bactericidal activities of betalactamases, amikacin, and fluorquinolones against Pseudomonas aeruginosa biofilm in artificial urine. Urology 53 (1999) 1058-1062
14. Hancock R.E., and Sahl H.G. Antimicrobial and host defense peptides as new antiinfective therapeutic strategies. Nat Biotechnol 24 (2007) 1551-1557
15. Hancock R.E., and Scott M.G. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97 (2000) 8856-8861
16. Hirakura Y., Kobayashi S., and Matsuzaki K. Specific interactions of the antimicrobial peptides cyclic β-sheet Tachyplesin I with lipopolysaccharides. Biochim Biophys Acta 1562 (2002) 32-36
17. Huttner K.M., and Bevins C.L. Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 45 (1999) 785-794
18. Joshi H.B., Stainthorpe A., MacDonagh R.P., Keeley F.X., and Timoney A.G. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169 (2003) 1065-1069
19. Koseoglu H., Aslan G., Esen N., Sen B.H., and Coban H. Ultrastructural stages of biofilm development of Escherichia coli on urethral catethers and effects of antibiotics on biofilm formation. Urology 68 (2006) 942-946
20. Kussell E., Kishony R., Balaban N.Q., and Libler S. Bacterial persistence: a model of survival in changing environments. Genetics 169 (2005) 1807-1814
21. Laube N., Kleinen L., Bradenahl J., and Messner A. Diamond-like carbon coatings on ureteral stents-a new strategy for decreasing the formation of crystalline bacterial biofilm?. J Urol 177 (2007) 1923-1927
22. Lee C.K., Rubin L.G., and Moldwin R.M. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms. Urology 45 (1995) 720-724
23. Lojanapiwat B. Colonization of internal ureteral stents and bacteriuria. World J Urol 24 (2006) 681
24. Mah T.C., and O'Toole G. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9 (2001) 34-39
25. Nakamura T., Furunaka H., Miyata T., Tokunaga F., Muta T., and Iwanaga S. Tachyplesin, a class of antimicrobial peptide from the hemocytes of horseshoe crab (Tachypleus tridentatus). J Biol Chem 263 (1988) 16709-16713
26. Paick S.H., Park H.K., Oh S.J., and Kim H.H. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stents. Urology 62 (2003) 214-217
27. Reid G., Denstedt J.D., Kang Y.S., Lam D., and Nause C. Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J Urol 148 (1992) 1592-1594
28. Roupret M., Daudon M., Hupertan V., Gattegno B., Thibault P., and Traxer O. Can ureteral stent encrustation analysis predict urinary stone composition?. Urology 66 (2005) 246-251
29. Russo P. Ureteral obstruction and stents: still a difficult problem for patients and urologists alike. J Urol 174 (2005) 2088
30. Tenke P., Kovacs B., Jäckel M., and Nagy E. The role of biofilm infection in Urology. World J Urol 24 (2006) 13-20
31. Yassien M., and Khardori N. Interaction between biofilms formed by Staphylococcus epidermidis and quinolones. Diagn Microbiol Infect Dis 40 (2001) 79-89